Saatja: 袁僮骏 <
[email protected]>
Saadetud: 14.04.2020 16:12
Adressaat: SM Info <
[email protected]>
Teema: Letter for fighting against COVID19
Tähtsus: Tavaline
Dear Sirs,
On 23rd, Feb, President Xi Jinping announced that China will enlarge
international and regional cooperation to fight against COVID-19, and
will provide necessary assistance to the countries and areas which are
affected by the virus. As China's largest medical and healthcare group,
Sinopharm has accumulated rich experiences in fighting against the
epidemic since the outbreak of COVID-19.We would like to report
Sinopharm's work in the prevention and control of the epidemics at home
and abroad, and wish to participate in international cooperation and
foreign assistance in this field.
Please find our letter and also we are at your dispoal anytime.
Regards,
Bruce
--
China Sinopharm International Corporation
Commercial Manager
Bruce Yuan
TEL:+387 66775601/+381 608310329
VIBER:+86 15910571651
Öйú¹ú¼ÊÒ½Ò©ÎÀÉúÓÐÏÞ¹«Ë¾
ÉÌÎñ¾Àí
Ô¬Ù׿¥
²¨ºÚµç»°£º+387 66775601/+381 608310329
¹úÄڵ绰£º+8615910571651
China Sinopharm International Corporation
Fortune Tower
No. 4, Huixin Dongjie
Chaoyang District
Beijing
China
April 14th, 2020
Subject: Letter for fighting against COVID19
On 23rd, Feb, President Xi Jinping announced that China will enlarge
international and regional cooperation to fight against COVID-19, and will provide
necessary assistance to the countries and areas which are affected by the virus. As
China's largest medical and healthcare group, Sinopharm has accumulated rich
experiences in fighting against the epidemic since the outbreak of COVID-19.
We would like to report Sinopharm's work in the prevention and control of the
epidemics at home and abroad, and wish to participate in international cooperation
and foreign assistance in this field.
I. Epidemic prevention and control
Supply medical protective materials in a timely manners. Entrusted by
Ministry of Industry and Information Technology, Sinopharm is responsible for
emergency medical materials reserve during the epidemic prevention and control
period. As at the end of February, Sinopharm has supplied 4.5 million sets of various
protective clothing, 535,500 pairs of goggles, 103.75 million pieces of masks, 46.4
million pairs of gloves, 470,500 sets of surgical gowns, 3.35 million bottles of
sterilization products and 12.54 million boxes of various medicines to different
medical facilities through Sinopharm’s global supply and distribution channels.
Develop New Drugs. Sinopharm firstly successfully developed the COVID-19
nucleic acid molecule detection kit, and proposed the solution for "treatment of
critically illed patients with the plasma from new cured COVID-19 patients" which
was included in the " COVID-19 Diagnosis and Treatment Plan" published by
the National Health Commission. "Pneumonia No. I” produced by Sinopharm got
94.21% of clinical effectiveness. In addition, Sinopharm is developing new vaccine to
address the epidemic.
Provide Medical treatment. There are 6 Sinopharm’s subsidiary medical
institutions and over 4200 medical staff working in Hubei Province which is the
frontline of the epidemic prevention and control. Sionpharm also plays an important
role in construction, operation and providing medical material supplies for
Huoshenshan (Fire God Mountain) hospital and Leishenshan (Thunder God Mountain)
hospital which are specialized hospitals for treating COVID-19 patients and were
built from scratch in two weeks at the epicenter of the outbreak.
Convergence of global resources. In response to the shortage of medical
supplies, Sinopharm explored multiple resources through different overseas’ channels,
and have imported more than 4.6 million medical supplies from 28 countries and
regions.
II. To involve in more international cooperation in epidemic prevention and
control
As the wholly-owned subsidiary of Sinopharm, China Sinopharm International
Corporation (Sinopharm International) has more than 10 overseas branch offices, and
shoulders Sinopharm’s strategic mission of developing international business.
Rencetly, entrusted by the China government, Sinopharm International has executed
more than 50 international medical materials aided projects with the purpose to help
other countries to fight against COVID-19, include Serbia, Crotia, Montenegro,
Greece etc.
In order to make full use of Sinopharm Group’s industrial advantages and rich
experiences gained from the COVID-19 prevention and control process, Sinopharm is
willing to involve in more international cooperation to fight against COVID-19. These
include:
1. Supply medical protective materials including masks, goggles, protective
clothing, and etc.
2. Supply medical devices and disposable products
3. Construction and reconstruction of emergency medical facilities.
4. Construction and reconstruction mobile hospital and mobile P2 Level
laboratory.
Sinopharm, as the flagship company of China's medical and pharmaceutical
industry, is willing to actively participate in the supply of various medical equipment
and disposables to help to provide epidemic prevention and control, and share China’s
experiences.
If you need any assistance, please contact us.
Contact:
Tong xin (Deputy general manager of Central and East Europe Branch),
[email protected]
Bruce Yuan (Assistant General Manager of Central and East Europe Branch ),
[email protected]
China Sinopharm International Corporation
April 14, 2020